Pyk2/ERK 1/2 mediate Sp1- and c-Myc-dependent induction of telomerase activity by epidermal growth factor

Growth Factors

Volumn 26, Issue 1, 2008, Pages 1-11

  Bermudez, Yira ^a   Yang, Hua ^a   Cheng, Jin ^b   Kruk, Patricia A ^a,b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

c Myc; Epidermal growth factor; ERK 1 2; Pyk2; Sp1; Telomerase

Indexed keywords

EPIDERMAL GROWTH FACTOR; FOCAL ADHESION KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYC PROTEIN; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; TRANSCRIPTION FACTOR SP1;

ARTICLE; BINDING SITE; CANCER CELL CULTURE; CARCINOGENESIS; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; EPITHELIUM CELL; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; UPREGULATION;

CELL LINE, TUMOR; CELL PROLIFERATION; EPIDERMAL GROWTH FACTOR; FEMALE; FOCAL ADHESION KINASE 2; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MODELS, BIOLOGICAL; OVARIAN NEOPLASMS; PROTO-ONCOGENE PROTEINS C-MYC; SP1 TRANSCRIPTION FACTOR; TELOMERASE;

EID: 41349109117     PISSN: 08977194     EISSN: 10292292     Source Type: Journal    
DOI: 10.1080/08977190802001389     Document Type: Article

References (69)

1. Akiyama, M., Hideshima, T., Hayashi, T., Tai, YT, Mitsiades, CS, Mitsiades, N., Chauhan, D., Richardson, P., Munshi, NC and Anderson, KC (2002) Cytokines modulate telomerase activity in a human multiple myeloma cell line. Cancer Res, 62, pp. 3876-3882.
2. Matte, MY Alfonso-De and Kruk, PA (2004) Phosphotidylinositol-triphosphate kinase- and c-jun N-terminal kinase-dependent induction of telomerase by calcium requires Pyk2. Cancer Res, 64, pp. 23-26.
3. Matte, MY Alfonso-De, Cheng, JQ and Kruk, PA (2001) Ultraviolet irradiation- and dimethyl sulfoxide-induced telomerase activity in ovarian epithelial cell lines. Exp Cell Res, 267, pp. 13-27.
4. Matte, MY Alfonso-De, Moses-Soto, H. and Kruk, PA (2002) Calcium induces telomerase activity in ovarian epithelial cell lines. Arch Biochem Biophys, 399, pp. 239-244.
5. Matte, MY Alfonso-De, Yang, H., Cheng, JQ, Evans, MS and Kruk, PA (2002) C-jun kinase-mediated regulation of telomerase in ovarian surface epithelial cells. Cancer Res, 62, pp. 4575-4578.
6. Avraham, H., Park, SY, Schinkmann, K. and Avraham, S. (2000) RAFTK/ Pyk2-mediated cellular signaling. Cell Signal, 12, pp. 123-133.
7. Bachand, F., Boisvert, FM, Cote, J., Richard, S. and Autexier, C. (2002) The product of the survival motor neuron (smn) gene is a human telomerase-associated protein. Mol Cell Biol, 13, pp. 3192-3202.
8. Bermudez, Y., Yang, H., Saunders, BO, Cheng, JQ, Nicosia, SV and Kruk, PA (2007) VEGF- and LPA-induced telomerase in human ovarian cancer cells is Sp1-dependent. Gynecol Oncol, 106, pp. 526-537.
9. Budiyanto, A., Bito, T., Kunisada, M., Ashida, M., Ichihashi, M. and Ueda, M. (2003) Inhibition of the epidermal growth factor receptor suppresses telomerase activity in HSC-1 human cutaneous squamous cell carcinoma cells. J Invest Dermatol, 121, pp. 1088-1094.
10. Carpenter, E. (2000) EGF receptor transactivation mediated by the proteolytic production of EGF-like agonists. Sci STKE, 2000, p. PE1.
11. Cong, YS, Wen, J. and Bacchetti, S. (1999) The human telomerase catalytic subunit hTERT: Organization of the gene and characterization of the promoter. Hum Mol Genet, 8, pp. 137-142.
12. Counter, CM, Hirte, HW, Bacchetti, S. and Harley, CB (1994) Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci USA, 91, pp. 2900-2904.
13. Counter, CM, Meyerson, M., Eaton, EN, Ellisen, LW, Caddle, SD, Haber, DA and Weinberg, RA (1998) Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase. Oncogene, 16, pp. 1217-1222.
14. D'Antonio, A., Losito, S., Pignata, S., Grassi, M., Perrone, F., De Luca, A., Tambaro, R., Bianco, C., Gullick, WJ, Johnson, GR, Iaffaioli, VR, Salomon, DS and Normanno, N. (2002) Transforming growth factor alpha, amphiregulin and cripto-1 are frequently expressed in advanced human ovarian carcinomas. Int J Oncol, 21, pp. 941-948.
15. Eversole, A. and Maizels, N. (2000) In vitro properties of the conserved mammalian protein hnRNPD suggest a role in telomere maintenance. Mol Cell Biol, 20, pp. 5425-5432.
16. Favata, MF, Horiuchi, KY, Manos, EJ, Daulerio, AJ, Stradley, DA, Feeser, WS, Van Dyk, DE, Pitts, WJ, Earl, RA, Hobbs, F., Copeland, RA, Magolda, RL, Scherle, PA and Trzaskos, JM (1998) Identification of a novel inhibitor of mitogen-activated protein kinase. J Biol Chem, 273, pp. 18623-18632.
17. Feng, J., Funk, W., Wang, S., Weinrich, S., Avilion, A., Chiu, C-P, Adams, R., Chang, E., Yu, J., Le, S., West, M., Harley, CB, Andrews, W., Greider, CW and Villeponteau, B. (1995) The human telomerase RNA component. Science, 269, pp. 1236-1241.
18. Fiset, S. and Chabot, B. (2001) hnRNP a1 may interact simultaneously with telomeric DNA and the human telomerase RNA in vitro. Nucleic Acids Res, 29, pp. 2268-2275.
19. Ford, LP, Suh, JM, Wright, WE and Shay, JW (2000) Heterogeneous nuclear ribonucleoproteins c1 and c2 associate with the RNA component of human telomerase. Mol Cell Biol, 20, pp. 9084-9091.
20. Fu, W., Begley, JG, Killen, MW and Mattson, MP (1999) Anti-apoptotic role of telomerase in pheochromocytoma cells. J Biol Chem, 274, pp. 7264-7271.
21. Greenberg, RA, O'Hagan, RC, Deng, H., Xiao, Q., Hann, SR, Adams, RR, Lichtsteiner, S., Chin, L., Morin, GB and DePinho, RA (1999) Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation. Oncogene, 18, pp. 1226-1291.
22. Haik, S., Gauthier, LR, Granotier, C., Peyrin, JM, Lages, CS, Dormont, D. and Boussin, FD (2000) Fibroblast growth factor 2 up regulates telomerase activity in neural precursor cells. Oncogene, 19, pp. 2957-2966.
23. Han, Y., Caday, CG, Nanda, A., Cavenee, WK and Huang, HJ (1996) Tyrphostin AG 1478 preferentially inhibits human glioma cells expressing truncated rather than wild-type epidermal growth factor receptors. Cancer Res, 56, pp. 3859-3861.
24. Hauck, CR, Hsia, DA and Schlaepfer, DD (2002) The focal adhesion kinase-A regulator of cell migration and invasion. IUBMB Life, 53, pp. 115-119.
25. Holbro, T. and Hynes, NE (2004) ErbB receptors: Directing key signaling networks throughout life. Annu Rev Pharmacol Toxicol, 44, pp. 195-217.
26. Holt, SE, Aisner, DL, Baur, J., Tesmer, VM, Dy, M., Ouellette, M., Trager, JB, Morin, GB, Toft, DO, Shay, JW, Wright, WE and White, MA (1999) Functional requirement of p23 and hsp90 in telomerase complexes. Genes Dev, 13, pp. 817-826.
27. Hoos, A., Hepp, HH, Kaul, S., Ahlert, T., Bastert, G. and Wallwiener, D. (1998) Telomerase activity correlates with tumor aggressiveness and reflects therapy effect in breast cancer. Int J Cancer, 79, pp. 8-12.
28. Johnson, NC and Kruk, PA (2002) BRCA1 zinc RING finger domain disruption alters caspase response in ovarian surface epithelial cells. Cancer Cell Int, 2, pp. 1-16.
29. Kamma, H., Fujimoto, M., Fujiwara, M., Matsui, M., Horiguchi, H., Hamasaki, M. and Satoh, H. (2001) Interaction of hnRNP a2/b1 isoforms with telomeric ssdna and the in vitro function. Biochem Biophys Res Commun, 280, pp. 625-630.
30. Kang, SS, Kwon, T., Kwon, DY and Do, SI (1999) Akt protein kinase enhances human telomerase activity through phosphorylation of telomerase reverse transcriptase subunit. J Biol Chem, 274, pp. 13085-13090.
31. Kanzaki, Y., Onoue, F., Ishikawa, F. and Ide, T. (2002) Telomerase rescues the expression levels of keratinocyte growth factor and insulin-like growth factor-II in senescent human fibroblasts. Exp Cell Res, 279, pp. 321-329.
32. Katakura, Y., Nakata, E., Miura, T. and Shirahata, S. (1999) Transforming growth factor beta triggers two independent-senescence programs in cancer cells. Biochem Biophys Res Commun, 255, pp. 110-115.
33. Kim, NW, Piatyszek, MA, Prowse, KR, Harley, CB, West, MD, Ho, PLC, Coviello, GM, Wright, WE, Weinrich, SL and Shay, JW (1994) Specific association of human telomerase activity with immortal cells and cancer. Sci, 266, pp. 2011-2015.
34. Kyo, S., Kanaya, T., Ishikawa, H., Ueno, H. and Inoue, M. (1996) Telomerase activity in gynecological tumors. Clin Cancer Res, 2, pp. 2023-2028.
35. Kyo, S., Takakura, M., Taira, T., Kanaya, T., Itoh, H., Yutsudo, M., Ariga, H. and Inoue, M. (2000) Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT). Nucleic Acids Res, 28, pp. 669-677.
36. Kyo, S., Masutomi, K., Maida, Y., Kanaya, T., Yatabe, N., Nakamura, M., Tanaka, M., Takarada, M., Sugawara, I., Murakami, S., Taira, T. and Inoue, M. (2003) Significance of immunological detection of human telomerase reverse transcriptase: Re-evaluation of expression and localization of human telomerase reverse transcriptase. Am J Pathol, 163, pp. 859-867.
37. Lahusen, T., Fereshteh, M., Oh, A., Wellstein, A. and Riegel, AT (2007) Epidermal growth factor receptor kinase phosphorylation and signaling controlled by a nuclear receptor coactivator, amplified in breast cancer 1. Cancer Res, 67, pp. 7256-7265.
38. Le, S., Sternglanz, R. and Greider, CW (2000) Identification of two RNA-binding proteins associated with human telomerase RNA. Mol Cell Biol, 11, pp. 999-1010.
39. Lev, S., Moreno, H., Martinez, R., Canoll, P., Peles, E., Musacchio, JM, Plowman, GD, Rudy, B. and Schlessinger, J. (1995) Protein tyrosine kinase PYK2 involved in Ca(2+)-induced regulation of ion channel and MAP kinase functions. Nature, 376, pp. 737-745.
40. Li, H., Pinto, AR, Duan, W., Li, J., Toh, BH and Liu, JP (2005) Telomerase down-regulation does not mediate PC12 pheochromocytoma cell differentiation induced by NGF, but requires MAP kinase signaling. J Neurochem, 95, pp. 891-901.
41. Lindvall, C., Hou, M., Komurasaki, T., Zheng, C., Henriksson, M., Sedivy, JM, Bjorkholm, M., Teh, BT, Nordenskjolk, M. and Xu, D. (2003) Molecular characterization of human telomerase reverse transcriptase-immortalized human fibroblasts by gene expression profiling: Activation of the epiregulin gene. Cancer Res, 63, pp. 1743-1747.
42. Maida, Y., Kyo, S., Kanaya, T., Wang, Z., Yatabe, N., Tanaka, M., Nakamura, M., Ohmichi, M., Gotoh, N., Murakami, S. and Inoue, M. (2002) Direct activation of telomerase by EGF through Ets-mediated transactivation of TERT via MAP kinase signaling pathway. Oncogene, 21, pp. 4071-4079.
43. Maines-Bandiera, SL, Kruk, PA and Auersperg, N. (1992) Simian virus 40-transformed human ovarian surface epithelial cells escape normal growth controls but retain morphogenetic responses to extracellular matrix. Am J Obstet Gynecol, 167, pp. 729-735.
44. Matsumura-Arioka, Y., Ohtani, K., Hara, T., Iwanaga, R. and Nakamura, M. (2005) Identification of two distinct elements mediating activation of telomerase (hTERT) gene expression in association with cell growth in human T cells. Int Immunol, 17, pp. 207-215.
45. Meyerson, M., Counter, CM, Eaton, EN, Ellisen, LW, Steiner, P., Caddle, SD, Ziaugra, L., Beijersbergen, RL, Davidoff, MJ, Liu, Q., Bacchetti, S., Haber, DA and Weinberg, RA (1997) hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell, 90, pp. 785-795.
46. Moore, MG, Wetterau, LA, Francis, MJ, Peehl, DM and Cohen, P. (2003) Novel stimulatory role for insulin-like growth factor binding protein-2 in prostate cancer cells. Int J Cancer, 105, pp. 14-19.
47. Nakayama, J., Saito, H., Nakamura, H., Matsuura, F. and Ishikawa, F. (1997) Tlp1: A gene encoding a protein component of mammalian telomerase is a novel member of wd repeats family. Cell, 88, pp. 875-884.
48. Ohyashiki, K., Ohyashiki, JH and Toyama, K. (1996) Technical improvement in determining telomerase activity in hematologic neoplasias: A possibility of single cell determination of telomerase activity. Hum Cell, 9, pp. 295-300.
49. Pai, R., Soreghan, B., Szabo, IL, Pavelka, M., Baatar, D. and Tarnawski, AS (2002) Prostaglandin E2 transactivates EGF receptor: A novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. Nat Med, 8, pp. 289-293.
50. Rosano, L., Castro, V Di, Spinella, F., Tortora, G., Nicotra, MR, Natali, PG and Bagnato, A. (2007) Cancer Res. Combined targeting of endothelin a receptor and epidermal growth factor receptor in ovarian cancer shows enhanced antitumor activity, 67, pp. 6351-6359.
51. Saito, T., Matsuda, Y., Suzuki, T., Hayashi, A., Yuan, X., Saito, M., Nakayama, J., Hori, T. and Ishikawa, F. (1997) Comparative gene mapping of the human and mouse TEP1 genes, which encode one protein component of telomerases. Genomics, 46, pp. 46-50.
52. Schreiber, E., Matthias, P., Muller, MM and Schaffner, W. (1989) Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res, 17, p. 6419.
53. Sewell, JM, Macleod, KG, Ritchie, A., Smyth, JF and Langdon, SP (2002) Targeting the EGF receptor in ovarian cancer with the tyrosine kinase inhibitor ZD 1839 ("Iressa"). Br J Cancer, 86, pp. 456-462.
54. Siemens, CH and Auersperg, N. (1988) Serial propagation of human ovarian surface epithelium in tissue culture. J Cell Physiol, 134, pp. 347-356.
55. Sigala, S., Faraoni, I., Botticini, D., Paez-Pereda, M., Missale, C., Bonmassar, E. and Spano, P. (1999) Suppression of telomerase, reexpression of KAI1, and abrogation of tumorigenicity by nerve growth factor in prostate cancer cell lines. Clin Cancer Res, 5, pp. 1211-1218.
56. Takakura, M., Kyo, T., Hirano, H., Takeda, J., Yutsudo, M. and Inoue, M. (1999) Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells. Cancer Res, 59, pp. 551-557.
57. Tanaka, Y., Miyamoto, S., Suzuki, SO, Oki, E., Yagi, H., Sonoda, K., Yamazaki, A., Mizushima, H., Maihara, Y., Mekada, E. and Nakano, H. (2005) Clinical significance of heparin-binding epidermal growth factor-like growth factor and a disintegrin and metalloprotease 17 expression in human ovarian cancer. Clin Cancer Res, 11, pp. 4783-4792.
58. Tokiwa, G., Dikic, I., Lev, S. and Schlessinger, J. (1996) Activation of Pyk2 by stress signals and coupling with JNK signaling pathway. Science, 273, pp. 792-794.
59. Tomlinson, RL, Ziegler, TD, Supakorndej, T., Terns, RM and Terns, MP (2006) Cell cycle-regulated trafficking of human telomerase to telomeres. Mol Biol Cell, 17, pp. 955-965.
60. Toyoda, H., Komurasaki, T., Uchida, D. and Morimoto, S. (1997) Distribution of mRNA for human epiregulin, a differentially expressed member of the epidermal growth factor family. Biochem J, 326, pp. 69-75.
61. Ulaner, GA, Hu, J-F, Vu, TH, Giudice, LC and Hoffman, AR (1998) Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts. Cancer Res, 58, pp. 4168-4172.
62. Ullrich, A., Coussens, L., Hayflick, JS, Dull, TJ, Gray, A., Tam, AW, Lee, J., Yarden, Y., Libermann, TA and Schlessinger, J. (1984) Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature, 309, pp. 418-425.
63. Van Dam, PA, Vergote, IB, Lowe, DG, Watson, JV, van Damme, P., van der Auwera, JC and Shepherd, JH (1994) Expression of c-erbB-2, c-myc, and c-ras oncoporteins, insulin-like growth factor receptor 1, and epidermal growth factor receptor in ovarian carcinoma. J Clin Pathol, 47, pp. 914-919.
64. Weinrich, SL, Pruzan, R., Ma, L., Ouellette, M., Tesmer, VM, Holt, SE, Bodnar, AG, Lichtsteiner, S., Kim, NW, Tragewr, JB, Taylor, RD, Carlos, R., Andrews, WH, Wright, WE, Shay, JW, Harley, CB and Morin, GB (1997) Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTERT. Nat Genet, 17, pp. 498-502.
65. Wetterau, LA, Francis, MJ, Ma, L. and Cohen, P. (2003) Insulin-like growth factor I stimulates telomerase activity in prostate cancer cells. J Clin Endocrinol Metab, 88, pp. 3354-3359.
66. Yang, H., Kyo, S., Takatura, M. and Sun, L. (2001) Autocrine transforming growth factor beta suppresses telomerase activity and transcription of human telomerase reverse transcriptase in human cancer cells. Cell Growth Differ, 12, pp. 119-127.
67. Yang, H., Ou, CC, Feldman, RI, Nicosia, SV, Kruk, PA and Cheng, JQ (2004) Aurora-A kinase regulates telomerase activity through c-Myc in human ovarian and breast epithelial cells. Cancer Res, 64, pp. 463-467.
68. Zervos, AS, Gyuris, J. and Brent, R. (1993) Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites. Cell, 72, pp. 223-232.
69. Zwick, E., Hackel, PO, Prenzel, N. and Ullrich, A. (1999) The EGF receptor as central transducer of heterologous signalling systems. Trends Pharmacol Sci, 20, pp. 408-412.